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Summary 
Echinococcosis is a re-emerging zoonotic disease in Kyrgyzstan. In 2012, an echinococcosis 
control scheme was started that included dosing owned dogs in the Alay Valley, Kyrgyzstan with 
praziquantel. Control programmes require large investments of money and resources; as such it 
is important to evaluate how well these are meeting their targets. However, problems associated 
with echinococcosis control schemes include remoteness and semi-nomadic customs of affected 
communities, and lack of resources. These same problems apply to control scheme evaluations, 
and quick and easy assessment tools are highly desirable. Lot quality assurance sampling was 
used to assess the impact of approximately two years of echinococcosis control in the Alay 
valley. A pre-intervention coproELISA prevalence was established, and a 75% threshold for 
dosing compliance was set based on previous studies. Ten communities were visited in 2013 and 
2014, with 18-21 dogs sampled per community, and questionnaires administered to dog owners. 
After 21 months of control efforts, 8/10 communities showed evidence of reaching the 75% 
praziquantel dosing target, although only 3/10 showed evidence of a reduction in coproELISA 
prevalence. This is understandable, since years of sustained control are required to effectively 
control echinococcosis, and efforts in the Alay valley should be continued.  
Keywords: Echinoccocus, control programme, Lot Quality Assurance Sampling (LQAS), 
Kyrgyzstan 
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Key findings 
• Prior to control efforts, canine echinococcosis coproELISA prevalence was estimated at 
20.1% 
• Praziquantel dosing targets of 75% of owned dogs were met in 8/10 communities after ~2 
years of control  
• CoproELISA prevalence did not decrease in all communities, indicating the need for 
continued control 
• Lot quality assurance sampling is a useful tool to evaluate the impact of echinococcosis 
control efforts 
Introduction 
Echinococcosis is a neglected zoonotic disease (WHO 2010) caused by infection with the larval 
stage of cestode tapeworms in the genus Echinococcus (Eckert et al. 2004). Human cystic and 
alveolar echinococcosis are caused by E. granulosus sensu lato (Alvares Rojas et al. 2014) and 
E. multilocularis, respectively (Eckert and Deplazes 2004), and humans are usually infected by 
eggs released in the faeces of an infected carnivore host, often domestic dogs (WHO/OIE 2001). 
Both diseases are characterized by the formation of cysts, usually in the liver or lungs 
(WHO/OIE 2001), and may be fatal if untreated (Fujikura 1991, Moro et al. 2009). 
Echinococcosis affects mainly pastoral communities worldwide, although the burden of the 
disease varies greatly in different locations (WHO/OIE 2001). Echinococcosis is relatively 
common in Central Asia (Torgerson et al. 2006, Torgerson 2013, Usubalieva et al. 2013), and is 
a public health concern in Kyrgyzstan (Torgerson et al. 2006). There are concerns the disease is 
re-emerging, and human cases of cystic and alveolar echinococcosis have increased greatly since 
Kyrgyzstan’s independence from the Soviet Union in 1991 (Torgerson et al. 2006, Usubalieva et 
al. 2013, Raimkylov et al. 2015).  
 
In 2011, the Kyrgyz Ministry for Agriculture and the World Bank considered echinococcosis to 
be of sufficient concern to implement an intervention programme which included providing 
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anthelmintics for dogs (World Bank 2010). Dosing of domestic dogs with praziquantel (PZQ) 
began in the summer of 2012, with an aim to dose all owned dogs four times a year (WHO 
2011). When implementing control programmes, it is important to evaluate how well these are 
meeting their targets (Schantz et al. 1995, Schantz 1997). However, as echinococcosis often 
affects rural and remote communities (Craig et al. 2007), the same challenges associated with 
implementing the control scheme will affect the evaluation of the control scheme itself. 
Relatively quick and easy evaluation tools are therefore beneficial to assess the impact of 
echinococcosis control schemes (see also van Kesteren et al. 2015). 
 
Coproantigen ELISAs have proved a useful diagnostic approach for canine echinococcosis 
(Allan et al. 2006, Craig et al. 2015). However, testing all dogs is difficult and therefore a sample 
of dogs is generally taken. In remote areas such as the Alay Valley, where communities and 
households may be scattered, it is difficult to attain large sample sizes for owned dogs not only 
because of logistical constraints, but also because many dogs are frequently free-roaming and 
people (and their dogs) may be semi-nomadic (van Kesteren et al. 2013). Lot quality assurance 
sampling (LQAS, Dodge et al. 1929), provides a statistically robust method of interpreting data 
despite requiring a relatively small sample size. The LQAS methodology has been adapted and 
simplified for application in field studies (Valadez et al. 2002), and has been applied to studies 
related to healthcare (see Robertson et al. 2006) and canine echinococcosis (van Kesteren et al., 
2015). In order to evaluate the echinococcosis intervention programme, ten communities in the 
Alay Valley were visited in April 2013 and April 2014 and LQAS methodology was applied to 
assess praziquantel dosing compliance, and canine echinococcosis coproELISA prevalence. 
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Methods 
Scheme for control of echinococcosis 
The Kyrgyz Ministry of Agriculture, with financial support from the World Bank, proposed an 
echinococcosis control programme (World Bank 2010). The proposal aimed to improve the 
livestock sector in Kyrgyzstan, specifically aiming to increase productivity and reduce zoonotic 
diseases (World Bank 2010). Funding was allocated to several programmes, including the 
development of a national disease control action plan, establishment of an animal disease 
surveillance system, implementation of a national public information campaign, and 
implementation of a comprehensive nationwide vaccination and testing program for eight 
diseases of livestock and/or dogs (foot and mouth disease, anthrax, rabies, brucellosis, sheep pox, 
peste des petits ruminants, echinococcosis, and tuberculosis). One proposed project was the 
provision of anthelminthics to domestic dogs in an attempt to control echinococcosis (World 
Bank 2010). 
 
Praziquantel tablets were provided to local community veterinarians at regional centres (for Alay 
Valley communities this was either Daroot Korgon or Gulcha), with community veterinarians 
instructed to go around to the households in their communities once in each season (winter, 
spring, summer and autumn) and either dose household dogs themselves or leave tablets with 
dog owners and instruct them to dose their dogs if dogs were not present at the time (T. Sultanov, 
Taldu Suu veterinarian, pers. comm.). In addition, veterinarians provided dog passports to 
monitor praziquantel dosing. The programme in the Alay Valley was considered a pilot project, 
and between 2013 and 2014, an estimated 7,610 dogs were registered with dog passports and 
dosed four times per year (unpublished data provided by the Kyrgyz Ministry of Agriculture and 
Land Reclamation and the Kyrgyz State Inspectorate for Veterinary and Phytosanitary Safety). 
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In 2015, the dosing campaign was expanded to other parts of Kyrgyzstan by the Kyrgyz Ministry 
of Agriculture, as well as being continued in the Alay Valley. Parallel to the dosing campaign, 
dog culling campaigns are implemented in Alay Valley communities. These are not specifically 
aimed at reducing echinococcosis but at controlling dog numbers. Prior to culls, which occur 
somewhat randomly during the year, and vary per village, community members are advised to 
tether or lock up their dogs for a specified period; untethered dogs are considered unwanted and 
culled (A. Gaitanbekov, Sary Mogul community veterinarian, pers. comm.). 
 
Communities 
Ten communities in the Alay Valley were selected as part of this study. All were situated along 
the major road (A327) that runs through the valley from west (the border with Tajikistan) to east 
(the border with Xinjiang, China). The communities sampled were (from west to east): Kyzyl 
Eshme (39.57°, 72.27°), Kabyk (39.59°, 72.39°), Achyk Suu (39.47°, 72.50°), Jaylima (39.62°, 
72.59°),  Kashka Suu (39.64°, 72.67°), Kara Kavak (39.66°, 72.72°), Sary Mogul (39.68°, 
72.89°), Taldu Suu (39.70°, 72.98°), Archa Bulak (39.69°, 73.08°) and Sary Tash (39.73°, 
73.25°) – see Figure 1. All communities were small villages with up to ~400 households, and 
populations of between a few hundred to at most ~3,000 people (see also van Kesteren et al. 
2013, Mastin et al. 2015). 
Establishing a pre-intervention coproELISA prevalence 
Four communities (Taldu Suu, Sary Mogul, Kara Kavak and Kashka Suu) were visited in May 
2012, prior to the start of the World Bank intervention programme (Mastin et al. 2015). All 
available households (i.e. those where occupants were at home at the time we visited) in Taldu 
Suu, Sary Mogul and Kara Kavak were visited, and all dogs present were sampled. If the 
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occupants of a house were not home, we selected a neighbouring house and inquired about the 
presence or absence of dogs in unavailable households to be able to accurately assess the dog 
population. Due to time constraints it was not possible to census all dogs In Kashka Suu. Instead, 
random locations within the community were selected and the six nearest available households 
were registered, with enquiries made about dog ownership of unavailable households at 
neighbouring households to be able to accurately assess the dog population. This process was 
continued until approximately 50 dogs had been registered in total. Based on estimation of total 
household numbers from satellite imagery, this process resulted in the registration of 
approximately 25% of all households in the villageThe number of dog faecal samples collected 
and analysed from each community was as follows: Kara Kavak=35, Kashka Suu=42, Sary 
Mogul=155, Taldu Suu=86 (Mastin et al. 2015).  
Lot Quality Assurance Sampling: faecal sample and questionnaire data collection 
A Lot Quality Assurance Sampling (LQAS) framework was adopted to evaluate the levels of 
canine echinococcosis in April 2013. A minimum of 19 dogs were sampled in Achyk Suu, Archa 
Bulak, Kabyk, Kyzyl Eshme, Jaylima and Sary Tash (a sample size of 19 is the smallest sample 
size that minimizes the risk of type A and B errors, see Valadez et al. 2002). To select dogs, a 
GPS coordinate for the centre of each community was determined using Google Earth images 
(based on imagery collected by the ‘SPOT5’ satellite in 2010). This location was taken as a 
starting point. Upon arriving at this point, the second hand on a watch was used to determine a 
random direction in which to walk, with a straight line then followed towards the edge of the 
community. Along this route, alternate households visited and if dogs were present they were 
sampled and questionnaires were administered to their owners. If a dead end or the end of the 
community was reached, the second hand of the watch was again used to determine at random a 
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new walking direction and the same approach was used, until a minimum of 19 dogs had been 
sampled, with additional dogs sampled if time allowed (however one sample collected from 
Achyk Suu in 2013 was lost in transport).  
 
In the remaining four communities (Taldu Suu, Sary Mogul, Kara Kavak and Kashka Suu), more 
extensive sampling was undertaken as part of another study in which all household sampled in 
2012 prior to the dosing campaign were sampled again in spring and autumn 2013 and 2014 to 
collect more detailed information on Echinococcus spp. in these communities with an aim to 
create a mathematical model of transmission (Mastin 2015, and Mastin et al., in prep). For these 
communities, maps of visited households were used to recreate the LQAS sampling approach – 
again, by selecting a theoretical start point in the centre of the community, choosing a random 
direction (using a watch) and selecting 19 sampled households in that direction from the ‘start 
point’, and including any dogs in these households. The number of samples analysed per 
community was as follows (shown as 2013;2014): Kyzyl Eshme=19;19, Kabyk=19;19, Achyk 
Suu=18;19, Jaylima=19;21, Kara Kavak=21;19, Kashka Suu=19;19, Sary Mogul=19;19, Taldu 
Suu=19;19, Archa Bulak=19;19 and Sary Tash=19;19.  
 
Dog owners were asked about the age and sex of their dogs, and when their dog was last dosed 
with PZQ. We expected that the start of the dosing campaign, as well as the start of an 
international research study on echinococcosis in the area, would increase awareness about 
echinococcosis in the local communities, as both veterinarians and researchers visiting local 
households often explained their work to dog owners. Also, the dosing campaign coincided with 
the appearance of public health notices on Kyrgyz television about echinococcosis (A. 
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Gaitanbekov and T. Sultanov, local veterinarians, pers. comm). Therefore, in 2014, dog owners 
were also asked if they had heard of echinococcosis, and if they knew what caused the disease. 
Questionnaires were administered in Kyrgyz by a native speaker (Bermet Mytynova). Faecal 
samples were collected from around the dog owner’s homes and subsamples were stored in 0.3% 
PBS Tween (Fisher Scientific, Loughborough, UK) with 10% formalin (sourced locally). Faecal 
samples were shipped at room temperature to the University of Salford, UK. 
 
The LQAS method was also used to determine whether the dosing programme was effectively 
reaching people in each community. Although praziquantel dosing schemes may aim to reach all 
owned dogs, it is unrealistic to assume a 100% compliance rate, with rates of <60% to >80% 
previously reported from Kenya and China (see Torgerson 2003). The World Bank aimed to 
dose dogs four times a year, and mathematical simulation models have shown that with dosing 
every 3-4 months, a compliance rate of 75% can be effective in reducing transmission of 
echinococcosis (Torgerson 2003, Torgerson et al. 2003a). For this reason we set our criterion at 
75% of dogs dosed in the four months prior to our visit. Because dog owners could often not 
remember the exact day of dosing, only the month was noted and all reported dosings in January, 
February, March and April were included as being within four months prior to our visit (samples 
were collected between 6 and 20 April 2013 and 5 and 12 April 2014). Where the latest dosing 
was not known, it was assumed the dog had not been dosed in the previous four months.  
 
Choosing LQAS decision numbers 
Although simplified field manuals including decision numbers are available for LQAS sampling  
(Valadez et al. 2002), it is possible to calculate decision numbers more accurately if the 
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population size and exact prevalence are known. This can be done using the hypergeometric 
distribution and applying the following formula (from Lemeshow et al. 1991): 
𝑃𝑃�𝑑𝑑 ≤ 𝑑𝑑 � = ��𝑁𝑁𝑃𝑃0𝑑𝑑 � �𝑁𝑁(1− 𝑃𝑃0)𝑛𝑛 − 𝑑𝑑 �
�𝑁𝑁
𝑛𝑛
�
𝑑𝑑
𝑑𝑑=0
 
Where N is the total dog population size in a community, P0 is the prevalence threshold, n is the 
number of dogs sampled, and d* is the decision number-1. The decision number must be an 
integer and should be the lowest possible integer at which P is greater than or equals 10%. If d* 
or fewer positive samples are obtained (i.e. if d is not reached), this is interpreted as some 
evidence that the true prevalence is lower than P0. For example, in Taldu Suu, a census of the 
dog population revealed there were 98 dogs in the community (N=98), the dosing target was set 
at 75% (P0=0.75), and the number of dogs sampled was 19. By adjusting d in the equation above, 
the probability of sampling at least d dosed dogs can be estimated, given that the true proportion 
of dosing was at least 75%. For n=11: 
�
�98 ∗ 0.7511 � �98(1− 0.75)19− 11 �
�9819� = 0.06
𝑑𝑑
𝑑𝑑=0
 
 For n=12: 
�
�98 ∗ 0.7512 � �98(1− 0.75)19− 12 �
�9819�
𝑑𝑑
𝑑𝑑=0
= 0.16 
As such the decision number for which P exceeds or equals 10% was calculated as 12, meaning 
that any sampling round which found fewer than 12 dosed dogs would provide some evidence 
that the true proportion of dosed dogs was lower than 75%. R code for calculation of the decision 
number based upon the hypergeometric distribution is provided in the Supplementary 
Information. 
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In order to calculate N, data collected in May 2012 from Sary Mogul, Taldu Suu and Kara Kavak 
was used, and extrapolated from the randomly sampled houses in Taldu Suu (for details see 
Mastin et al. 2015). The size of the four villages was estimated using the ‘measure distance’ tool 
in Google Earth, to select the area that contained most of the houses. The number of dogs (from 
census data) was then divided by the area of the villages to give an estimate of the dog density 
(average of 1.56 dogs/100m2, SE=0.30). The sizes of the other six communities were then 
estimated using Google Earth and the dog population estimated using the average dog density of 
1.56 dogs/ha from the four main study villages (Table 1). It is worth noting that dog population 
numbers in the Alay Valley do fluctuate due to a bi-annual dog culling campaign. The data from 
May 2012 was collected just prior to dog culling and as such the dog population numbers shown 
in Table 1 are estimates extrapolated from populations that had not recently been culled. Because 
of this, and the irregular nature of the dog culling, we may have overestimated the dog 
populations present in some communities, which could affect decision numbers, particularly for 
communities with small dog populations. However sensitivity analysis found that even if dog 
populations were overestimated by a third, LQAS results for dosing compliance and 
coproELISA prevalence would not change, so uncertainty of exact population sizes is not 
considered further.  
 
P0 was set at the pre-intervention prevalence as calculated from the samples collected from Sary 
Mogul, Taldu Suu, Kashka Suu and Kara Kavak in 2012, and n was determined as the number of 
dogs sampled in each community in each year (18, 19 or 21). For praziquantel dosing, P0 was set 
at 75% (Torgerson 2003, Torgerson and Heath 2003a). 
12 
 
 
CoproELISA 
Details of the coproELISA are given in Mastin et al. (2015). Briefly, after decontaminating at -
80°C for ≥4 days (WHO/OIE 2001), faecal samples were extracted by homogenizing, shaking, 
and centrifuging at 2500r.p.m (1125g) for 5 minutes, and collecting the supernatant. Faecal 
samples were analysed for Echinococcus spp. coproantigen using a genus-specific sandwich 
ELISA (see Allan et al. 1992, Craig et al. 1995, van Kesteren et al. 2015). Supernatants of two 
known positive samples (one natural infection, one sample spiked with E. granulosus adult 
worm extract) were used as positive controls throughout. Three known coproELISA negatives 
from a very low endemic area (Falkland Islands) were also included as negative controls.  
 
The ‘pre-intervention’ faecal samples collected in May 2012 and the post intervention samples 
collected (LQAS) in April 2013 and April 2014 were analysed in two batches. Aliquots of all 
reagents were pooled to a sufficient volume to test all the faecal samples in each lot and mixed, 
to ensure minimum variation in coproELISA test conditions.  
 
Cut-offs for OD values were determined for the coproELISA using ROC curve panels (Gardner 
et al. 2006) of faecal samples of known infection status. These panels included arecoline purge 
samples from dogs in the Alay Valley (van Kesteren et al. 2013) and samples from necropsied 
dogs in communities in Hobukesar County, Xinjiang China (van Kesteren et al. 2015). The aim 
was to compare the pre-intervention data to the data collected in April 2013 and 2014, and as 
such cut-offs were chosen to give similar sensitivities (Se) and specificities (Sp) between the two 
batches of samples, rather than choosing cut-offs that necessarily maximized Se/Sp. For the pre-
intervention samples (May 2012) a cut-off was chosen that gave a diagnostic sensitivity of 90% 
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and a specificity of 86%. For the post-intervention ‘LQAS’ samples (April 2013 and April 2014) 
a cut-off was chosen that gave a diagnostic sensitivity of 89% and a specificity of 88% (Note that 
for this reason the pre-intervention coproELISA prevalence described here is different from that 
described in Mastin et al. 2015, which used a cut-off to maximize Se and Sp). 
 
Results 
Pre-intervention coproELISA prevalence 
The dog faecal samples collected in May 2012 (n=318) gave an overall average coproELISA 
prevalence of 20.1%, with a within-village range from 16.3% in Taldu Suu to 22.9% in Kara 
Kavak. Village differences were ignored for the purposes of the current study, and the P0 for 
coproELISA prevalence was therefore set at 20.1% 
Dog demographics and praziquantel dosing in April 2013 and April 2014 
A total of 191 dogs were sampled in April 2013. The majority of these (157 or 82.2%) were 
male, with 28 females (14.7%). For six dogs (3.1%) the sex was not recorded. Most dogs were 
younger than five years (131, or 69.3%, see Fig. 2, although the age of ten dogs was not 
recorded, and for 6 dogs neither age nor sex was recorded. 
 
A total of 192 dogs were sampled in April 2014. The majority of these (156 or 81.3%) were 
male, with 35 females (18.2%). The sex of one dog (0.5%) was not recorded. Most dogs were 
younger than five years (156 or 81.3%, Fig. 3), and for 5 dogs the age/sex was not recorded. 
                                                        
In 2013, the majority of dog owners reported dosing their dog at some point in the seven months 
before sampling (141, or 73.8%, Fig. 4), with one person reportedly dosing their dog 11 months 
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before sampling (0.5%). However 39 dog owners (20.42%) reported never dosing their dogs, and 
a further 10 owners (5.2%) did not know when their dog had last been dosed, if ever (Fig. 4). In 
2014, 152 dog owners (79.2%, Fig. 4) reported dosing their dog in the seven months before 
sampling, with four dogs (2.1%) being dosed between 7 and 8 months prior to sampling. In 2014, 
23 dog owners (12.0%) reported never dosing their dogs and for a further 13 dogs (6.8%), the 
latest dosing was not known (Fig. 4). 
Local knowledge of echinococcosis 
In 2014, dog owners were asked whether or not they had heard of human echinococcosis, and 
what they thought caused human echinococcosis (open question). A total of 149 dog owners 
were asked these questions (some owners had multiple dogs, and some owners did not answer 
these questions). For the cause of echinococcosis, answers were classified as either ‘correct’, 
‘incorrect’ or ‘partially correct’. ‘Correct’ answers included: dog faeces, foxes, wolves, and 
contact with dogs. If owners correctly identified dogs and dog faeces as possible sources of 
infection but also listed incorrect sources such as sheep or mice (which are potential sources of 
canine echinococcosis, but not human infection), these were classed as ‘partially correct’. If 
owners said they didn’t know what caused echinococcosis, or gave wrong responses, for 
example ‘livers’ (which would be correct for canine echinococcosis but not human 
echinococcosis) then the answer was classed as ‘incorrect’. Out of the 149 respondents, 126 
(84.6%) had heard of echinococcosis, and 93 of these (78.3%) correctly identified causes of 
echinococcosis, with a further 13 respondents (10.3%) giving partially correct responses. 23 dog 
owners (15.4%) had not heard of echinococcosis and could not correctly identify its causes, but 
of the respondents who had heard of echinococcosis, 20 could also not correctly identify its 
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causes. As such a total of 43 dog owners (28.9%) could not correctly identify causes of 
echinococcosis. 
Using the LQAS method to evaluate PZQ dosing 
Although the majority of dogs were dosed in the four months prior to sampling in 2013 (109, or 
56.5%), there were marked differences between villages. None of 19 dogs were dosed in the 
previous four months in Sary Mogul in 2013, compared to 16 out of 19 dogs dosed in Jaylima in 
2013 (Table 2). Six out of ten communities (Archa Bulak, Kara Kavak, Kashka Suu, Kyzyl 
Eshme, Sary Mogul, Sary Tash) did not meet the LQAS decision number for praziquantel 
dosing, suggesting that the praziquantel dosing scheme failed to reach at least 75% of owned 
dogs in these communities in 2013 (see Table 2). 
In 2014, the overall proportion of dogs dosed no more than four months prior to sampling was 
higher than in 2013 (128, or 66.7%). Dosing compliance rates also seemed to have improved, 
with only two communities (Kashka Suu and Kyzyl Eshme) failing to meet the decision number 
(see Table 2). This suggests that the praziquantel dosing scheme was reaching more owned dogs 
in 2014 than in 2013. 
Using LQAS to evaluate the impact of two years of intervention on coproELISA prevalence 
The LQAS methodology described above was also used to evaluate whether the coproELISA 
prevalence had decreased following the start of the intervention programme. P0 was set at 
20.13% based on the pre-intervention sampling, and we aimed to identify villages that had 
achieved a reduction in their coproELISA prevalence.  
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In 2013, five communities in the Alay valley (Archa Bulak, Kara Kavak, Kashka Suu, Sary 
Mogul and Sary Tash) did not meet the decision number set according to LQAS requirements 
(Table 3). In 2014, three communities (Archa Bulak, Jaylima, and Sary Tash) did not meet the 
LQAS decision number (Table 3). These results provide some evidence that the canine 
coproELISA prevalence in these communities was lower than the pre-intervention value of 
20.13%. 
 
Discussion 
 Echinococcosis is a neglected zoonotic disease that can be fatal in humans (WHO/OIE 2001) 
and can also have a large economic impact on rural communities due to the detrimental effects 
on livestock productivity (Benner et al. 2010). Echinococcosis is re-emerging in Kyrgyzstan 
(Torgerson et al. 2003b, Raimkylov et al. 2015) and was specifically mentioned as one focus of a 
livestock disease control programme in the country (World Bank 2010). However, 
echinococcosis is very difficult to control or eliminate (WHO/OIE 2001) especially in 
continental regions that are relatively remote and where people are nomadic or semi-nomadic 
(Schantz et al. 2003, Craig et al. 2006). In these cases frequent praziquantel dosing of domestic 
dogs (standard recommended dosing every six weeks) may not be practically feasible (Gemmell 
et al. 1986, Lembo et al. 2013), and surveillance of the effectiveness of the scheme in the field is 
made even more challenging. 
 
The implementation of control programmes for echinococcosis is costly in terms of both 
financial and human resources, and as a result, control programmes have frequently not had the 
long term success hoped for (Craig and Larrieu 2006). As such, it is important to evaluate the 
real impact of control programmes, rather than focussing on easily-available metrics such as the 
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amount of money spent, or the number of praziquantel tablets distributed. Effective evaluation of 
control programmes requires data to be collected from the communities in question, including 
reliable pre-intervention data, and data collection should continue at suitable intervals during the 
control programme itself. The data collected will depend on the questions being asked, but of 
particular value are infection-centred measures such as the prevalence of canine infection (or the 
copro-prevalence, as a proxy), or the prevalence of human echinococcosis. However, the 
challenges of implementing control programmes will also apply to the evaluations of control 
programmes. As such, relatively quick and easy tools to evaluate echinococcosis control 
programmes are highly desirable. 
 
In order to evaluate the impact of the intervention programme in the Alay Valley, a pre-
intervention coproELISA prevalence was established (van Kesteren et al. 2013, Mastin et al. 
2015). To assess the impact of the control programme, ten communities were visited in April 
2013 and April 2014 (~9 and 21 months after the start of the dosing scheme). From these, we 
aimed to assess praziquantel dosing compliance and coproELISA prevalence, with the 
praziquantel dosing threshold set at 75% of dogs dosed in the previous 3-4 months (Torgerson 
2003). In 2013, four of the ten communities reached the decision number associated with this 
dosing target, and in 2014 this number had increased to eight out of ten. Although the LQAS 
methodology does not allow us to state that the target was reached for these communities, the 
number of communities for which there was evidence of the target not being met was lower in 
2014 than 2013, which is suggestive that the dosing scheme was reaching at least 75% of owned 
dogs in most communities sampled. Furthermore, in 2014 a majority of dog owners (84.6%) had 
heard of human echinococcosis and could describe its causes (78.3%).  
18 
 
 
In 2013, there was evidence that the copro-prevalence was lower than the pre-intervention 
estimate of 20.13% in five out of ten communities sampled. However, in 2014, this had 
decreased to three out of the ten communities sampled, despite the higher number of 
communities reaching the threshold for reported praziquantel dosing. Although LQAS 
methodology, by virtue of the small sample sizes collected, does not lend itself well to 
individual-level interpretation, it was reported that over half of the 33 dogs found to be 
coproELISA positive in 2014 were reported to have been dosed within the previous four months. 
This may reflect information biases from owners regarding the timing of dosing, errors in dosing 
(for example, tablets not swallowed or incorrect dosages administered), or reinfection. Although 
praziquantel is highly effective in treating canine echinococcosis, it provides no protection 
against reinfection, and if dogs continue to have access to offal and/or small mammals, they may 
become re-infected with E. granulosus, E. canadensis or E. multilocularis: all three of which are 
known to be transmitted in dogs in the Alay valley (van Kesteren et al. 2013). Deworming dogs 
using praziquantel is considered to eventually reduce the infection pressure to dogs through 
decreasing the infection pressure to livestock and small mammals, although this takes time due 
to the longevity of cysts in livestock (e.g. Torgerson and Heath 2003a). Similarly, although the 
lifespan of voles and other small mammals is much shorter than that of sheep (Bobek 1969, 
Devevey et al. 2009), it will take 1-2 years for infected small mammals to die off (Moss et al. 
2013). Furthermore, E. multilocularis transmission is expected to be less responsive to dog 
dosing campaigns due to its sylvatic lifecycle (Eckert and Deplazes 2004). Therefore, even if 
dogs were correctly dosed, they may still be subject to high reinfection pressures, which may 
explain the poor correlation between reported praziquantel dosing and coproELISA prevalence.  
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When using LQAS, it is important to be aware of the limitations of this methodology. LQAS 
methodology remains statistically robust in the presence of small sample sizes by operating on 
the group level rather than the individual level, and by classifying groups (in the current study, 
villages) in a dichotomous fashion. As a result, conclusions can only be made at the level of the 
village, and individual-level associations within these villages cannot be assessed. This latter 
issue means that although possible reasons for a lack of association between praziquantel dosing 
and coproantigen positivity at the individual dog level can be postulated (see above), further 
studies would be required to evaluate this more fully. Another important consideration in 
interpreting the results presented here is that of limitations in the diagnostic test itself. It has been 
well reported that the coproantigen ELISA functions best in the presence of higher worm 
burdens (Allan and Craig 2006). Control schemes using anthelminthics may affect the degree of 
overdispersion in a community since treatment of high burden individuals (which contribute 
most to overdispersion) bring the mean worm burden closer to the threshold for detection using 
the coproantigen ELISA, resulting in greater instability in the prevalence estimates obtained 
when using a single cut-off for ‘positivity’. It should also be noted that as pre-intervention 
coproELISA prevalences were estimated from the four communities (Sary Mogul, Taldu Suu, 
Kara Kavak and Kashka Suu) sampled prior to the dosing campaign, we are not able to draw 
detailed conclusions about individual communities, which would require more extensive data 
collection (e.g. Mastin 2015, Mastin et al. 2015). 
 
Surveillance of echinococcosis in domestic dogs allows for a practical evaluation of a control 
programme, with the benefit that dogs can be sampled and tested for Echinococcus spp. non-
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invasively through coproELISA analysis of faecal samples collected from the ground (e.g. 
Pierangeli et al. 2010). In addition, the application of novel sampling methodology like LQAS 
can reduce some of the laboriousness associated with evaluating control programmes, and 
provide a relatively quick and easy tool to test if control programmes are meeting their targets. 
Here we found evidence that a minority of villages failed to reach reasonable levels of 
praziquantel dosing by 2014, suggesting that the echinococcosis control programme was 
reaching the other communities. Although analysis of the canine infection data did not show 
evidence of a gradual decrease in coproELISA prevalence over time, longer timescales are 
required to evaluate these changes. Effective control of echinococcosis takes years if not 
decades, and a sustained effort will be required to reduce infection pressures and effectively 
control cystic echinococcosis in the Alay Valley, and the co-endemicity with alveolar 
echinococcosis in the Alay valley (Usubalieva et al. 2013) also makes control more challenging. 
Fortunately control efforts in the Alay Valley by the Kyrgyz Ministry of Agriculture are 
ongoing, with an estimated ~6,000 and ~4,000 dogs treated in 2015 and 2016 respectively, with 
an estimated total of 24,162 and 15,501 praziquantel tablets provided to dogs (unpublished data 
provided by the Kyrgyz Ministry of Agriculture and Land Reclamation and the Kyrgyz State 
Inspectorate for Veterinary and Phytosanitary Safety). Following the initial project in the Alay 
Valley, the control programme has been expanded to other parts of Kyrgyzstan. The LQAS 
methodology described here would provide a relatively low-cost method of evaluating canine 
infection status over the coming years, given that the control scheme is maintained. 
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Table1: Estimated dog populations in the 10 communities sampled.  
* indicates known dog number from census 
 ** indicates extrapolated dog number from sample 
Village name Estimated area 
(ha) 
Estimated dog 
number 
Estimated dog density 
(dogs per ha) 
Taldu Suu 37 98* 2.66 
Sary Mogul 121 157* 1.30 
Kara Kavak 31 35* 1.12 
Kashka Suu 105 120** 1.14 
Archa Bulak 16 25 1.57 
Sary Tash 56 90 1.61 
Kabyk 29 50 1.71 
Kyzyl Eshme 68 105 1.56 
Achyk Suu 61 95 1.56 
Jaylima 17 30 1.74 
 
Table 2: Dogs dosed in the four months prior to sampling in each of the ten communities in April 
2013 and April 2014. Communities in bold type did not meet the LQAS requirements, meaning 
that for these communities there was evidence that fewer than 75% of households had recently 
dosed their dogs with praziquantel 
 
 
 
 
Community PZQ in prev. 4 ms No PZQ in prev. 4 ms Decision # Community PZQ in prev. 4 ms No PZQ in prev. 4 ms Decision #
Achyk Suu 13 5 11 Achyk Suu 16 3 12
Archa Bulak 11 8 13 Archa Bulak 17 2 13
Jaylima 16 3 13 Jaylima 19 2 14
Kabyk 15 4 12 Kabyk 14 5 12
Kara Kavak 10 11 14 Kara Kavak 16 3 12
Kashka Suu 10 9 12 Kashka Suu 5 14 12
Kyzyl Eshme 12 7 12 Kyzyl Eshme 4 15 12
Sary Mogul 0 19 12 Sary Mogul 13 6 12
Sary Tash 7 12 12 Sary Tash 17 2 12
Taldu Suu 15 4 12 Taldu Suu 16 3 12
2013 2014
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Table 3: CoproELISA positive and negative faecal samples in the ten communities sampled in 
April 2013 and April 2014. Communities in bold type met the LQAS requirements, meaning that 
for these communities there was no evidence of a decrease in coproantigen prevalence from the 
baseline of 20.1% 
 
 
 
  
Community CoproELISA +ve CoproELISA -ve Decision # Community CoproELISA +ve CoproELISA -ve Decision #
Achyk Suu 4 14 2 Achyk Suu 5 14 2
Archa Bulak 1 18 3 Archa Bulak 0 19 3
Jaylima 6 13 2 Jaylima 2 19 3
Kabyk 4 15 2 Kabyk 4 15 2
Kara Kavak 1 20 3 Kara Kavak 2 17 2
Kashka Suu 1 18 2 Kashka Suu 5 14 2
Kyzyl Eshme 3 16 2 Kyzyl Eshme 7 12 2
Sary Mogul 0 19 2 Sary Mogul 4 15 2
Sary Tash 1 18 2 Sary Tash 0 19 2
Taldu Suu 2 17 2 Taldu Suu 4 15 2
2013 2014
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Figure legends: 
Figure 1: Locations of the study sites within Kyrgyzstan (top) and a region of southern 
Kyrgyzstan (bottom). KE = Kyzyl Eshme; Ka = Kabyk; AS = Achyk Suul; Ja = Jaylima; KS = 
Kashka Suu; KK = Kara Kavak; SM = Sary Mogul; TS = Taldu Suu; AB = Archa Bulak; ST = 
Sary Tash 
Figure 2: Dog demographics in the Alay Valley in April 2013, based on LQAS sampling of ten 
communities. (Note: age and/or sex of 16 dogs not recorded) 
 Figure 3: Dog demographics in the Alay Valley in April 2014, based on LQAS sampling of ten 
communities. (Note: age and/or sex of 5 dogs not recorded) 
Figure 4: Most recent praziquantel dosing for dogs in the Alay Valley in April 2013 and April 
2014 
 
